Goodwin: FogPharma Completes $145M Series E Financing
March 06, 2024
March 06, 2024
BOSTON, Massachusetts, March 6 -- Goodwin, a law firm, issued the following news release:
The Life Sciences team advised FogPharma on the closing of its $145 million Series E financing round. The financing was led by Nextech Invest with participation from other new investors including RA Capital Management, Rock Springs Capital, General Catalyst, Marshall Wace, Samsara Biocapital, Foresite Capital, Symbiosis, Catalio Capital Management, Sixty Degree Capital and former chairman and C . . .
The Life Sciences team advised FogPharma on the closing of its $145 million Series E financing round. The financing was led by Nextech Invest with participation from other new investors including RA Capital Management, Rock Springs Capital, General Catalyst, Marshall Wace, Samsara Biocapital, Foresite Capital, Symbiosis, Catalio Capital Management, Sixty Degree Capital and former chairman and C . . .